The BRICS Biomed Cooperation plans to establish BRICS Biomed centres in Kanyakumari, Bangalore, Hyderabad and Delhi by 2025.
S G Prakash Vincent, Chairman Associate BRICS-Biomed (India- Academic), said the aim of the consortium is to provide affordable and novel medicines. There are global opportunities in Biomed and it will witness an investment of 5 billion dollars and 50 billion dollars returns are expected between 2015 and 2021.
Shamil Akhmedov, Chairman of the BRICS-Biomed, Cardiology Research Institute, Tomsk NRMC, Tomshk, Russia, said the main aim of creation of the BRICS-Biomed Consortium is the development of new biomedical technologies for diagnosis and treatment of human diseases, development of domestic demand and export of biotech products, creation of technological base for new biotech areas of industrial sector.
Akhmedov said the objectives of the consortium were promotion of expertise on innovative projects with respect to the technological feasibility and commercial potential of research and development; conductance of marketing studies, accumulation of information on market demands in particular innovative technological solutions; preparation of proposals for The New Development Bank on possible financing of particular innovative projects; search for co-investors; implementation of collaborative R&D and engineering; assistance in business organization; assistance in patenting; and assistance in creation of spin-off companies.
All rights reserved by Rossiyskaya Gazeta.